Analysts showing optimistic trends for Ichor Holdings(NASDAQ:ICHR): TG Therapeutics, Inc.(NASDAQ:TGTX)

0
1

Ichor Holdings (ICHR) will report its next earnings on Feb 05 AMC. The company reported the earnings of $0.48/Share in the last quarter where the estimated EPS by analysts was $0.5/share. The difference between the expected and actual EPS was $-0.02/share, which represents an Earnings surprise of -4%.

Many analysts are providing their Estimated Earnings analysis for Ichor Holdings and for the current quarter 7 analysts have projected that the stock could give an Average Earnings estimate of $0.64/share. These analysts have also projected a Low Estimate of $0.55/share and a High Estimate of $0.7/share.

In case of Revenue Estimates, 7 analysts have provided their consensus Average Revenue Estimates for Ichor Holdings as 221.86 Million. According to these analysts, the Low Revenue Estimate for Ichor Holdings is 208 Million and the High Revenue Estimate is 228.2 Million. The company had Year Ago Sales of 135.41 Million.

These analysts also forecasted Growth Estimates for the Current Quarter for ICHR to be 160%. They are projecting Next Quarter growth of 182.61%. For the next 5 years, Ichor Holdings is expecting Growth of 25.46% per annum, whereas in the past 5 years the growth was 116.8% per annum.

Some buy side analysts are also providing their Analysis on Ichor Holdings, where 1 analysts have rated the stock as Strong buy, 0 analysts have given a Buy signal, 0 said it’s a HOLD, and 0 analysts rated the stock as Sell. (These Recommendations are for the Current Month Only reported by Yahoo Finance.)

The Relative Volume of the company is 1.73 and Average Volume (3 months) is 409.06 million. The company’s P/E (price to earnings) ratio is 38.61 and Forward P/E ratio of 5.5.

The company shows its Return on Assets (ROA) value of 2.1%. The Return on Equity (ROE) value stands at 5.1%. While it’s Return on Investment (ROI) value is 5.4%.

While looking at the Stock’s Performance, Ichor Holdings currently shows a Weekly Performance of -13.34%, where Monthly Performance is -42.47%, Quarterly performance is -46.89%, 6 Months performance is -31.22% and yearly performance percentage is -18%. Year to Date performance value (YTD perf) value is -45.93%. The Stock currently has a Weekly Volatility of 21.73% and Monthly Volatility of 11.89%.

TG Therapeutics, Inc. (TGTX) will report its next earnings on Mar 03 BMO. The company reported the earnings of $-0.44/Share in the last quarter where the estimated EPS by analysts was $-0.46/share. The difference between the expected and actual EPS was $0.02/share, which represents an Earnings surprise of 4.3%.

Many analysts are providing their Estimated Earnings analysis for TG Therapeutics, Inc. and for the current quarter 4 analysts have projected that the stock could give an Average Earnings estimate of $-0.37/share. These analysts have also projected a Low Estimate of $-0.49/share and a High Estimate of $-0.27/share.

These analysts also forecasted Growth Estimates for the Current Quarter for TGTX to be 7%. They are projecting Next Quarter growth of 7.14%. For the next 5 years, TG Therapeutics, Inc. is expecting Growth of 50.03% per annum, whereas in the past 5 years the growth was 19.67% per annum.

Some buy side analysts are also providing their Analysis on TG Therapeutics, Inc., where 2 analysts have rated the stock as Strong buy, 0 analysts have given a Buy signal, 0 said it’s a HOLD, and 0 analysts rated the stock as Sell. (These Recommendations are for the Current Month Only reported by Yahoo Finance.)

The Relative Volume of the company is 1.38 and Average Volume (3 months) is 2.1 million. The company’s P/E (price to earnings) ratio is 0 and Forward P/E ratio of 0.

The company shows its Return on Assets (ROA) value of -143.9%. The Return on Equity (ROE) value stands at 0%. While it’s Return on Investment (ROI) value is -249.3%.

While looking at the Stock’s Performance, TG Therapeutics, Inc. currently shows a Weekly Performance of 33.42%, where Monthly Performance is -32.98%, Quarterly performance is 1.09%, 6 Months performance is 69.77% and yearly performance percentage is 45.17%. Year to Date performance value (YTD perf) value is -7.93%. The Stock currently has a Weekly Volatility of 17.89% and Monthly Volatility of 14.02%.

SHARE